Can the shingles vaccine and the influenza vaccine be administered on the same day to an 80-year-old patient with chronic obstructive pulmonary disease (COPD)?

Yes, shingles and flu vaccines can and should be given on the same day to this patient.

Both the recombinant zoster vaccine (RZV/Shingrix) and inactivated influenza vaccine can be safely administered concomitantly to your 80-year-old COPD patient, and doing so is explicitly recommended by current guidelines to avoid missed vaccination opportunities 1, 2.

Key Evidence Supporting Same-Day Administration

Guideline Recommendations

The 2024 ACIP influenza guidelines specifically address this scenario 2:

• Inactivated influenza vaccines can be administered simultaneously with RZV at separate anatomic sites
• Coadministration of RZV with nonadjuvanted inactivated influenza vaccine (IIV4) showed no evidence of decreased immunogenicity or safety concerns 2
• A randomized controlled trial in adults ≥65 years found that severe local or systemic reactions were not higher with simultaneous RZV and adjuvanted influenza vaccine compared to RZV with high-dose influenza vaccine 2

The 2024 Taiwan guidelines on herpes zoster vaccination provide a weak recommendation with moderate quality evidence (2B) that RZV can be given concomitantly with seasonal influenza vaccine 1.

COPD-Specific Considerations

Your patient's COPD diagnosis is not a contraindication and actually strengthens the indication for both vaccines:

• Influenza vaccination is safe in COPD patients: A large cohort study of 12,000 individuals with asthma or COPD found no increased risk of adverse acute outcomes in the first 2 weeks after influenza vaccination 3
• RZV is effective in COPD patients: A 2024 multi-institutional study demonstrated RZV reduced herpes zoster risk by 38% (HR 0.62) in COPD patients aged ≥50 years, with consistent benefits across age groups including those ≥80 years 4
• Combined vaccination benefits: Studies show influenza and pneumococcal vaccination together provide 72% effectiveness in preventing COPD exacerbations 5

Practical Administration Guidelines

Injection site management:

• Administer vaccines in separate anatomic sites (different arms preferred) 2
• If using adjuvanted influenza vaccine (e.g., Fluad), give in different limbs if possible due to higher local reaction rates 2

Reactogenicity counseling:

• Most reactogenicity symptoms resolve within 4 days 2
• RZV causes more systemic side effects than influenza vaccine 1
• Important caveat: Patients receiving concurrent vaccines may misattribute RZV's systemic side effects to the influenza vaccine, potentially reducing willingness to receive influenza vaccine in subsequent years 1

Alternative consideration:

• If using a nonadjuvanted influenza vaccine option, you can consider this to minimize cumulative adjuvant exposure, though vaccination should not be delayed if a specific vaccine formulation is unavailable 2

Clinical Bottom Line

For your 80-year-old COPD patient, simultaneous administration is the preferred approach because:

1. It maximizes vaccination completion rates
2. Both vaccines are safe and effective in COPD patients
3. COPD patients are at high risk for both influenza and herpes zoster complications
4. Evidence supports no clinically significant safety concerns with coadministration
5. Delaying either vaccine increases risk of missed vaccination opportunities

Administer both vaccines today in separate arms, counsel about expected side effects (particularly from RZV), and document that most symptoms resolve within 4 days.